Immunology
173.7K views | +6 today
Follow
Immunology
Teaching and Learning Immunology. Information you never would have searched for!
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

Fatty acid metabolism in the regulation of T cell function: Trends in Immunology

Highlights

 

•T effector cell differentiation depends on de novo fatty acid (FA) synthesis.•CD8+ T memory cell development and function depend on both FA synthesis and oxidation.•FA synthesis and oxidation are determinants for CD4+ T effector versus Treg cell development.•These pathways may present therapeutic targets for modulating T cell responses in vivo.

 

The specific regulation of cellular metabolic processes is of major importance for directing immune cell differentiation and function. We review recent evidence indicating that changes in basic cellular lipid metabolism have critical effects on T cell proliferation and cell fate decisions. While induction of de novo fatty acid (FA) synthesis is essential for activation-induced proliferation and differentiation of effector T cells, FA catabolism via β-oxidation is important for the development of CD8+ T cell memory as well as for the differentiation of CD4+ regulatory T cells. We consider the influence of lipid metabolism and metabolic intermediates on the regulation of signaling and transcriptional pathways via post-translational modifications, and discuss how an improved understanding of FA metabolism may reveal strategies for manipulating immune responses towards therapeutic outcomes.


Via Krishan Maggon
Krishan Maggon 's curator insight, February 22, 2015 4:24 AM

Trends in Immunology  Volume 36, Issue 2, p81–91, February 2015

 

 

Fatty acid metabolism in the regulation of T cell functionMatthias Lochner*, Luciana Berod*, Tim SparwasserInstitute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany*These authors contributed equally to this work. DOI: http://dx.doi.org/10.1016/j.it.2014.12.005
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? | Immunology | Scoop.it

Dendritic cells, macrophages and B cells are regarded as the classical antigen-presenting cells of the immune system. However, in recent years, there has been a rapid increase in the number of cell types that are suggested to present antigens on MHC class II molecules to CD4+ T cells. In this Review, we describe the key characteristics that define an antigen-presenting cell by examining the functions of dendritic cells. We then examine the functions of the haematopoietic cells and non-haematopoietic cells that can express MHC class II molecules and that have been suggested to represent 'atypical' antigen-presenting cells. We consider whether any of these cell populations can prime naive CD4+ T cells and, if not, question the effects that they do have on the development of immune responses.


Via Krishan Maggon
Gilbert C FAURE's insight:

and epithelial cells in autoimmunity

Krishan Maggon 's curator insight, November 15, 2014 9:22 AM
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?Taku Kambayashi& Terri M. LauferAffiliationsCorresponding authorNature Reviews Immunology 14, 719–730 (2014) doi:10.1038/nri3754Published online 17 October 2014